Product
Empasiprubart
Aliases
ARGX-117 concentrate for solution, Empasiprubart IV
1 clinical trial
2 indications
Indication
DermatomyositisIndication
MyositisClinical trial
A Phase 2, Randomized, Double-Blinded, Placebo-Controlled, Multicenter Study to Evaluate the Safety, Tolerability, and Efficacy of Multiple Dose Regimens of Empasiprubart in Adults With DermatomyositisStatus: Not yet recruiting, Estimated PCD: 2025-07-18